Johnson & Johnson has launched the Pitching Asia Pacific Oncology Innovation QuickFire Challenge to help identify the next generation of anticancer therapeutics that leverage precision approaches targeted to tumor and tumor microenvironment (TME). Innovators are invited to submit novel modalities and technologies with the potential to deliver targeted and precise treatments in Hematologic Malignancies as well as Lung, Bladder, Prostate, and/or Colorectal Cancers. Applications will be reviewed on a rolling basis and invitations to present will be extended May-July.
713-782-3777
